What changed in ARGENX SE's 2025 10-K compared to 2024?

Across the narrative sections we track, ARGENX SE (ARGX) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this ARGX 10-K diff come from?

The source filings are ARGENX SE's official 2024 and 2025 Form 6-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

ARGENX SEARGX決算レポート

Nasdaq · pharmaceutical industry

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.

What changed in ARGENX SE's 6-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other ARGX 10-K year-over-year comparisons

ARGX 10-K 2023 vs 2024
ARGX 10-K 2022 vs 2023